Pleiotropic Stromal Effects of Vascular Endothelial Growth Factor Receptor 2 Antibody Therapy in Renal Cell Carcinoma Models

by Duignan, Inga J, Corcoran, Erik, Pennello, Anthony, Plym, Mary Jane, Amatulli, Michael, Claros, Nidia, Iacolina, Michelle, Youssoufian, Hagop, Witte, Larry, Samakoglu, Selda, Schwartz, Jonathan, Surguladze, David, Tonra, James R
Published 2011

Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma

by Armand, Philippe, Janssens, Ann, Gritti, Giuseppe, Radford, John, Timmerman, John, Pinto, Antonio, Mercadal Vilchez, Santiago, Johnson, Peter, Cunningham, David, Leonard, John P., Rodig, Scott J., Martín-Regueira, Patricia, Sumbul, Anne, Samakoglu, Selda, Tang, Hao, Ansell, Stephen M.
Published in Blood (2021)

Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study

by Ansell, Stephen M., Minnema, Monique C., Johnson, Peter, Timmerman, John M., Armand, Philippe, Shipp, Margaret A., Rodig, Scott J., Ligon, Azra H., Roemer, Margaretha G.M., Reddy, Nishitha, Cohen, Jonathon B., Assouline, Sarit, Poon, Michelle, Sharma, Manish, Kato, Kazunobu, Samakoglu, Selda, Sumbul, Anne, Grigg, Andrew
Published in J Clin Oncol (2019)